Archives for September 12, 2004

← 2004

Energy costs drive up price of packaging

Soaring energy costs are driving up the price of packaging materials. Anthony Fletcher looks at the state of the market for polyethylene, polypropylene and polystyrene.

New dye reveals proteins in living cells

A new method to improve the accuracy and speed of protein visualization has been developed. The technique, which uses a novel set of biosensor dyes, promises to dramatically increase the accuracy and speed of the technique, used in the pharmaceutical...

UBC Discovery is gateway to new stroke treatments

A whole new generation of drug treatments and therapies for stroke, migraine, Alzheimer's and other brain disorders could be created after the discovery of a mechanism for regulating brain blood flow was made by researchers.

Akzo Nobel reveals Chinese ambitions

The chief executive of Akzo Nobel expects to record sales of more than $1 billion in China within the next five years, more than double the level at present, and is boosting its presence in the country in anticipation.

Record results buoy Aceto

US chemical company Aceto has reported a healthy rise in sales and operating income in the year ended 30 June, helped by its recent entry into the market for biopharmaceuticals.

DSM cuts production costs with new vitamin E plant

DSM Nutritional Products has lifted its vitamin E capacity to 25,000 tons - the world's largest - at a new plant that is being hailed for its production efficiencies, reports Dominique Patton.

Nucleonics challenges Benitec's patent validity

Biotechnology Company, Nucleonics, has filed a request with the Commissioner of Patents in Australia for Re-Examination, which questions the validity of Benitec's patent concerning gene-silencing technology claiming ambiguity and lack adequate...

Bioject wins new client for vial adaptor

Needle free injector specialist Bioject Medical Technologies has won a new contract to supply its drug vial adaptor product, designed to make syringe filling completely needle free.

Bayer revamp continues with US alliance

By  Wai Lang Chu

Bayer has continued the sweeping reforms across its business with the creation of a broad pharmaceuticals alliance with US drugmaker Schering-Plough.

Serologicals merges with the Upstate Group

US life science company Serologicals has entered into a €167.6 million merger with cell signallin specialist Upstate, creating a significant presence in the preclinical drug screening and target validation market, the fastest growing segment of the...

Proliant takes on cell culture rival

Proliant Biologicals has launched a new cell culture medium that can be used for the production of monoclonal antibodies and other proteins but is claimed to be more economical than a rival product.